News
To treat glioblastoma, Purdue researchers are developing antibody-based immunotherapies to improve the recruitment and ...
Technological advances empower the modification of NK cells and renewed potential for therapeutic uses in cancer and ...
With groundbreaking innovations in vaccines and immunotherapy, Medigen Biomedical Group is revolutionizing healthcare, and ...
11d
The Brighterside of News on MSNLifesaving new vaccine protects against multiple types of cancerWhen your body senses something is wrong—whether it's a damaged cell or a growing tumor—it can react in many ways. One of the ...
Get Instant Summarized Text (Gist) Genetically modified natural killer (NK) cells have shown potential in cancer immunotherapy by overcoming tumor defenses. Using CRISPR/Cas9, researchers ...
The bone marrow environment evolves in ways that support the cancer, and I’m a firm believer that to treat cancer effectively ...
A supplemental Biologics License Application has been submitted to the FDA for Anktiva plus BCG in papillary NMIBC.
Yago Nieto, MD, PhD, discusses AFM13, how it works, and its effect as a bispecific antibody that targets CD30 and CD16.
New research reveals 5 ways exercise enhances cancer treatment effectiveness, offering hope to patients with chronic ...
Among other functions, the NK cells (Natural Killers, a type of lymphocyte forming part of the immune system) have the capacity to detect and eliminate cancer cells. But in some cases they cannot ...
In a syngeneic mouse model, the suppression of DDX54 led to significant increases in the infiltration of anti-cancer immune ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results